Recipient of federal assistance · SAINT LOUIS, MO

UNANDUP, LLC

UNANDUP, LLC received $694.9K in federal grants and other assistance in FY2026, on 5 actions, −2.6% vs FY2025. It has no federal contracts in the loaded years. Since FY2021: $10.9M. Its largest awarding agency was National Institutes of Health ($694.9K).

Assistance · FY2026
$694.9K
New awards
1
Actions
5
Since FY2021
$10.9M
UEI
KS8GMBKHNKV3
Location
SAINT LOUIS, MO
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 1.7MFY2021
  2. 3MFY2022
  3. 2.5MFY2023
  4. 2.3MFY2024
  5. 713.6KFY2025
  6. 694.9KFY2026

By type

  1. Grants$694.9K100%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 93.395 · Cancer Treatment Research$405.8K58%
  2. 93.837 · Cardiovascular Diseases Research$289.2K42%

Awarding agencies

  1. National Institutes of Health$694.9K100%
    Department of Health and Human Services

Largest awards

  1. LOW-DOSE MAGNETO-THROMBOLYSIS TO EXPAND STROKE CARE - ACUTE ISCHEMIC STROKE (AIS) RESULTS FROM A BLOOD CLOT IN THE NEUROVASCULATURE AND IS…$3.3M
    93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders· National Institutes of Health· Project grant· Jun 19, 2023 – Jul 14, 2026· R44NS132605
  2. AN IMPROVED ROBOTIC ELECTROPHYSIOLOGY PLATFORM FOR ARRHYTHMIA ABLATION - ARRHYTHMIAS RESULT FROM DISORGANIZED ELECTRICAL SIGNALS WITHIN THE…$2.7M
    93.837 · Cardiovascular Diseases Research· National Institutes of Health· Project grant· Sep 13, 2022 – Jul 2, 2026· R44HL147745
  3. MAGNETIC ROTATIONAL PLATFORM FOR CORONARY LESIONS - CARDIOVASCULAR DISEASE (CVD) IS THE LEADING CAUSE OF MORTALITY IN THE UNITED STATES…$702.8K
    93.837 · Cardiovascular Diseases Research· National Institutes of Health· Project grant· Apr 16, 2025 – May 12, 2026· R43HL178364
  4. IMPROVED MAGNETOMOTIVE EMBOLIZATION FOR HEPATOCELLULAR CARCINOMA - CANCER IS THE 2ND LEADING CAUSE OF DEATH IN THE UNITED STATES (US) AND…$405.8K
    93.395 · Cancer Treatment Research· National Institutes of Health· Project grant· Sep 1, 2026 – Sep 1, 2026· R43CA310649
  5. COMMERCIALIZATION READINESS PILOT FOR FLOW ACCELERATION FOR STROKE THROMBOLYSIS (FAST) SYSTEM - ACUTE ISCHEMIC STROKE (AIS) RESULTS FROM A…$300K
    93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders· National Institutes of Health· Project grant· Mar 14, 2025 – Feb 26, 2026· SB1NS139910

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2026.